Skip to main content

Advertisement

Log in

Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Neutropenia and/or neutrophil dysfunction are part of glycogen storage disease type 1b (GSD1b) phenotype. Recent studies indicated that activation of apoptosis and increased reactive oxygen species are implicated in the pathogenesis of neutropenia in GSD1b.

Methods

We studied seven GSD1b patients over a 2-year-period to evaluate the efficacy of vitamin E, a known antioxidant, in preventing or improving the clinical manifestations associated with neutropenia and neutrophil dysfunction. Frequency and severity of infections, neutrophil counts and function, ileocolonoscopy and intestinal histology, were monitored. During the first year, patients did not assume vitamin E; during the second year of the study, vitamin E supplementation was added to their therapeutic regimens.

Results

During vitamin E supplementation, the mean values of neutrophil counts were significantly higher (p < 0.05) and neutrophil counts lower than 500/mm3 were found less frequently (p < 0.05); the frequency and severity of infections, mouth ulcers and perianal lesions, was reduced (p < 0.05); ileocolonoscopy and histology showed a mild improvement. Vitamin E supplementation did not result in changes in neutrophil function.

Conclusions

These results suggest that vitamin E supplementation might be beneficial in GSD1b patients and may alleviate disease manifestations associated with neutropenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aprikyan AA, Liles WC, Park JR, Jonas M, Chi EY, Dale DC (2000) Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 95:320–327

    PubMed  CAS  Google Scholar 

  2. Aprikyan AA, Liles WC, Rodger E, Jonas M, Chi EY, Dale DC (2001) Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood 97:147–153. doi:10.1182/blood.V97.1.147

    Article  PubMed  CAS  Google Scholar 

  3. Burton GW, Webb A, Ingold KU (1985) A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 20:29–39. doi:10.1007/BF02534359

    Article  PubMed  CAS  Google Scholar 

  4. Chen YT (2001) Glycogen storage disease. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Kinzler V (eds) The metabolic and molecular bases of inherited disease 8th edn. McGraw-Hill, New York, pp 1521–1551

    Google Scholar 

  5. Chou JY, Matern D, Mansfield BC, Chen YT (2002) Type I glycogen storage disease: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2:121–143. doi:10.2174/1566524024605798

    Article  PubMed  CAS  Google Scholar 

  6. Donadieu J, Barkaoui M, Bezard F, Bertrand Y, Pondarre C, Guibaud P (2000) Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony 233. Stimulating factor therapy. J Pediatr Hematol Oncol 22:188–189. doi:10.1097/00043426-200003000-00028

    Article  PubMed  CAS  Google Scholar 

  7. Galli L, Orrico A, Marcolongo P, Fulceri R, Burchell A, Melis D, Parini R, Gatti R, Lam C, Benedetti A, Sorrentino V (1999) Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c. FEBS Lett 459:255–258. doi:10.1016/S0014-5793(99)01248-X

    Article  PubMed  CAS  Google Scholar 

  8. Geerling BJ, Badart-Smook A, van Deursen C, van Houwelingen AC, Russel MG, Stockbrügger RW, Brummer RJ (2000) Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn’s disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6:77–84

    PubMed  CAS  Google Scholar 

  9. Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T, Griffiths A (2005) Pediatric inflammatory bowel disease collaborative research group. Evaluation of the pediatric Crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 41:416–421. doi:10.1097/01.mpg.0000183350.46795.42

    Article  PubMed  Google Scholar 

  10. Ishiguro A, Nakahata T, Shimbo T (1993) Improvement of neutropenia and neutrophil dysfunction by granulocyte colony stimulating factor in patients with in glycogen storage disease type Ib. Eur J Pediatr 152:18–20

    Article  PubMed  CAS  Google Scholar 

  11. Kim SY, Nguyen AD, Gao JL, Murphy PM, Mansfield BC, Chou JY (2006) Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions.. J Biol Chem 281:28794–28801. doi:10.1074/jbc.M604964200

    Article  PubMed  CAS  Google Scholar 

  12. Kuijpers TW, Maianski NA, Tool AT, Smit GP, Rake JP, Roos D, Visser G (2003) Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 101:5021–5024. doi:10.1182/blood-2002-10-3128

    Article  PubMed  CAS  Google Scholar 

  13. Lei KJ, Shelly LL, Lin B, Sidbury JB, Chen YT, Nordlie RC, Chou JY (1995) Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest 95:234–240. doi:10.1172/JCI117645

    Article  PubMed  CAS  Google Scholar 

  14. Leuzzi R, Banhegyi G, Kardon T, Marcolongo P, Capecchi PL, Burger HJ, Benedetti A, Fulceri R (2003) Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood 101:2381–2387. doi:10.1182/blood-2002-08-2576

    Article  PubMed  CAS  Google Scholar 

  15. Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, Terrin G, Cucchiara S, Andria G (2003) Crohn’s-like ileo-colitis in patients affected by glycogen storage disease Ib: two years’ follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr 92:1415–1421. doi:10.1080/08035250310007033

    Article  PubMed  CAS  Google Scholar 

  16. Olcay L, Yetgin S, Erdemli E, Germeshausen M, Aktaş D, Büyükaşik Y, Okur H (2008) Congenital dysgranulopoietic neutropenia. Pediatr Blood Cancer 50:115–119. doi:10.1002/pbc.20877

    Article  PubMed  Google Scholar 

  17. Pinsk M, Burzynski J, Yhap M, Fraser RB, Cummings B, Ste-Marie M (2002) Acute myelogenous leukemia and glycogen storage disease 1b. J Pediatr Hematol Oncol 24:756–758. doi:10.1097/00043426-200212000-00015

    Article  PubMed  Google Scholar 

  18. Rake JP, Visser G, Huismans D, Huitema S, van der Veer E, Piers DA, Smit GP (2003) Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study. J Inherit Metab Dis 26:371–384 . doi:10.1023/A:1025111220095

    Article  PubMed  CAS  Google Scholar 

  19. Santoro P, Cacciapuoti C, Palumbo A, Graziano D, Annunziata S, Capasso L, Formisano S, Ciccimarra F (1998) Effects of wortmannin on human neutrophil respiratory burst and phagocytosis. Ital J Biochem 47:13–18

    PubMed  CAS  Google Scholar 

  20. Seidner DL, Lashner BA, Brzezinski A, Banks PL, Goldblum J, Fiocchi C, Katz J, Lichtenstein GR, Anton PA, Kam LY, Garleb KA, Demichele SJ (2005) An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3:358–369. doi:10.1016/S1542-3565(04)00672-X

    Article  PubMed  CAS  Google Scholar 

  21. Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GP (2000) Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 137:187–191. doi:10.1067/mpd.2000.105232

    Article  PubMed  CAS  Google Scholar 

  22. Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Smit GP (2002) European Study on Glycogen Storage Disease Type I. Consensus guidelines for management of glycogen storage disease type 1b-European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 161(Suppl 1):S120–3

    PubMed  Google Scholar 

  23. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A (2002) Radical trapping in glycogen storage disease 1a. Eur J Pediatr 161(Suppl 1):S70–4

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We are grateful to “Associazione Italiana Glicogenosi” (AIG) and AIFA–Italian Agency of Medicine- who strongly supported the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Parenti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melis, D., Della Casa, R., Parini, R. et al. Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b. Eur J Pediatr 168, 1069–1074 (2009). https://doi.org/10.1007/s00431-008-0889-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-008-0889-5

Keywords

Navigation